chrisvoncsefalvay/vaers-outcomes huggingface dataset:
7/24/17- 102-104 fever. 7/25/17- to Dr., ATB given in case of UTI, ATB started. 7/26/17- continued fever, rash noted on back. 7/27/17- rash head to toe, no itching, small red pinpoint rash, to Dr. stop ATB. 7/28/17- fever broke in middle of night, continued rash. 7/30/17- rash lessened. 8/1/17- rash only in few spots.
It was reported that a 15 month old male received vaccines on 11/11/99 at 11:00. Reportedly, at 11:30, the pt's ears and eyes began to swell, developed generalized hives an experienced some respiratory symptoms, "hard time breathing" along with coughing. Treatment of Solu-Medrol IV, Benadryl and Prelone were given. The pt reportedly recovered from this experience. From additional information received on 1/10/00, the correct IPOL lot number (P0658) was provided.
Patient's wife stated that he was feeling muscle soarrness & planning on going to MD's office to get Cortizone shot.
History of present illness:  Patient was admitted after she fell, she was found on the floor by her family, she was on the floor for over 12 hr, she denied hitting her head, she denied any syncopal episodes, she was tachycardic with heart rate as high as 177, Cardiology was consulted, labs were suggestive of acute kidney injury and Nephrology was consulted, INR was elevated and sodium level was low.   Hospital Course:  Patient was seen by Nephrology for acute kidney injury, advised fluid resuscitation since this was felt to be secondary to dehydration, she was given IV fluids, however, BUN and creatinine failed to improve, CPK was markedly elevated on admission and was slowly trending down, she was seen by Cardiology and advised intravenous diltiazem in addition to Toprol-XL, echocardiogram was done and showed ejection fraction 60%, moderately dilated left atrium, it was felt that DC cardioversion may be considered once she was more stable.  Test for corona virus disease 19 came back positive, patient reported that she had received 2 doses of vaccine for corona virus disease 19, she denied shortness of breath, she was treated with vitamin-C, zinc, vitamin-D.  She was noted to have diarrhea, stool negative for C diff, positive for leukocytes, stool was also positive for occult blood, seen by Gastroenterology, advised to transfuse as needed and colonoscopy as well as possible EGD as outpatient.  There was concern regarding diverticulitis on imaging, she was treated with ceftriaxone and metronidazole.  Gram-positive bacteremia was noted, 1/2 blood cultures, initially given vancomycin, subsequently vancomycin stopped since microbiology showed coagulase negative staph and patient was already having renal problems.  She was nauseous in the evening on February 11th, electrolyte abnormalities were being corrected, she had emesis and subsequently developed respiratory failure, she went into asystole and was not breathing, CPR was initiated and carried on for approximately 20 min, she was pulseless for about 20 min, she was intubated and moved to the intensive care unit in the evening on February 11th with a consult to Critical Care.  After discussion with multiple family members by Critical Care, decision was made to focus care on comfort only, ventilator placed on standby, patient was noted without vital signs early morning on February 12
Facial flushing, mild redness to chest and bilateral upper extremities .  Completely resolved by next morning.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. The patient was vaccinated with live ZOSTAVAX within the last 6 months. No other co-suspects were reported. No concomitant medications were reported. On the day of administration, the patient experienced rash after receiving live ZOSTAVAX, The rash started to get better within 24 hours and developed right below the injection site and down to the patient's elbow. No treatment was given. No labs diagnostic studies were performed. The patient did not seek medical attention. The relatedness for rash is unknown for live ZOSTAVAX. Additional information has been requested.
chills; body pain; didn't feel good; This spontaneous case was reported by a patient and describes the occurrence of CHILLS (chills), PAIN (body pain) and FEELING ABNORMAL (didn't feel good) in a 66-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis.     The patient's past medical history included COVID-19 (last summer).    In September 2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. In September 2023, the patient experienced CHILLS (chills), PAIN (body pain) and FEELING ABNORMAL (didn't feel good). In September 2023, CHILLS (chills) and PAIN (body pain) had resolved. On 23-Sep-2023, FEELING ABNORMAL (didn't feel good) had resolved.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were provided.   This case was linked to MOD-2023-743153 (Patient Link).
Diagnosed with ITP (idiopathic thrombolytic purpura) 2/4/2007, 32 days after administration of Varicella and MMR vaccines.
symptoms pain in left arm continue April 6, 2021 every day went to see doctor on April 14, 2021 was prescribe a inflammation and muscle relaxer.  Left arm continue to hurt the next day with finger tips on left hand begin to tingle, I call my doctor he sent me to have a ultra sound of my left arm and do blood work. upper extremity duplex ultrasound
Patient stated her arm felt sore on10/15/2014. When she went to take a shower she noticed it was red and slightly swollen at the site of injection. On 10/16/2014 it continues sore and red. She saw CRNP and showed her her arm and reported her symptoms to her (CRNP is employed here also) and was instructed to take Advil, which she took 400mg at 10AM on 10/16/2014. She has been instructed to report additional symptoms or/and worsening of symptoms.
On the afternoon of 10/19/01, the arm that the yellow fever was taken in, there was itching, swelling and a large red circle with about a 4" papular rash. No fever.
Received 3 mRNA vaccinations, last Pfizer vaccine 3/2022. Dx w/ COVID beginning of June, Received Paxvolid + antibody infusion but then required hospitalization on 6/17 for weakness, some worsening SOB. Had recently been seen in ER for ileus , N/V which has led to some malnutrition (pt not eating 6 days prior to admit). Pt also found to have leukopenia + thrombocytopenia. WBC 1.09, plts 51 on admit.
Patient under age 18 was vaccinated with Moderna 020B21A, which is a vaccine error, on 4/2/2021. He received his second vaccine  Moderna  008C21A on 4/30/2021, Troubleshooting: Neither original dose vaccinator/screener nor second dose vaccinator validated birthdate.  Unreported as error, found in data mining. He was eligible for the second vaccine per standing orders. A policy requiring vaccinators/scribes to check age was instituted shortly after his first vaccine to prevent this from occurring again.
pt recvd vax & immed to 2 hrs devel inflammation at inject site;exp swelling,size of a large egg & pain at inject site;ice was applied to inject site;outcome:no proble;
5 doses of the Moderna Covid-19 Vaccine were given past the beyond use date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (5 doses of the Moderna Covid-19 Vaccine were given past the beyond use date) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (5 doses of the Moderna Covid-19 Vaccine were given past the beyond use date). On 25-Jan-2022, EXPIRED PRODUCT ADMINISTERED (5 doses of the Moderna Covid-19 Vaccine were given past the beyond use date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.  The vial was used past the beyond use date of 15-Jan-2022. On 16-Dec-2021, the vial was initially stored in refrigerator. The vial did not undergo any temperature excursion issues.
My daughter started vomiting while nursing on Friday the 27th of September around 8 PM. She continued vomiting until it was all completely bile. She then became very lethargic while we were on our way to the hospital. I counted a total of 10 times vomiting even while asleep in the car seat. It was all still bile. They did not run any tests at hospital that night and sent us home with Zofran and said it was just a "bug" that was going around. Three days later on 9/30 she started the vomiting again. We went to call her primary doctor but they had no available openings so we went to another facility. They did the same thing as the first facility and just sent us home even though she was very dehydrated. The very next night she started getting feverish. Her temperature went up to around 103 degrees Fahrenheit. This lasted for four nights. And for three days now she has had a splotchy patchy rash that is irritating to her.
Double vision going to opthamologist now neurological optomosologist next week neurologist; This is a spontaneous report from a contactable consumer (patient). A 53-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: Er8737, Expiration date: Not reported) via an unspecified route of administration in right arm on an unspecified date as single dose for COVID-19 immunization. The patient's medical history included high blood pressure. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. No known allergies. Concomitant medication included losartan (within 2 weeks of vaccination). Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: Er8730, Expiration date: not reported), via an unspecified route of administration in left arm on 27Mar2021 10:00 (at the age of 53-year-old) as single dose for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced double vision going to opthamologist now neurological optomosologist next week neurologist on 12May2021. Adverse event resulted in doctor or other healthcare professional office/clinic visit, Disability or permanent damage. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 11Jun2021 Nasal Swab. It was unknown if patient received treatment for the event. Outcome of the event was not recovered.  No follow-up attempts needed. No further information expected.
Narrative: Nursing home to hospital ER, Covid+, Moderna x 3, cough, fatigue, pulse less without respiration, decrease appetite, morbid obesity, seizure due to the patients enchephalonalacia from prior stroke. Home on keppra
HCP just prescribed doxycycline; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (HCP just prescribed doxycycline) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE DRUG REACTION (HCP just prescribed doxycycline). The patient was treated with DOXYCYCLINE at an unspecified dose and frequency. At the time of the report, ADVERSE DRUG REACTION (HCP just prescribed doxycycline) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication were reported.  Patient's HCP just prescribed doxycycline. Patient would like to know if they should take the second dose of the vaccination.
Swelling, redness around site of ZOSTAVAX, back of (R) arm. Staph infx.
Chest pains, shortness of breath, stabbing shooting pain on left side of the chest, weakness, pain and numbers on left arm, painful cramping and stabbing pain of the left side of the chest radiating shooting pain to left arm led to ER visit on 10/08/21, admitted and released 10/10/21. Recurrence on 11/22 and 11/23 led to ER visits.  As a runner, HR norm is always low at 45-85 bmp and BP at 100/70 (average) on ER visit BP was 129/80 with HR of 98, felt heart pounding and winded, medication given to lower BP.
a little lethargic; throat had a weird scratchy tickle; fast heart beating; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL DISCOMFORT (throat had a weird scratchy tickle), HEART RATE INCREASED (fast heart beating) and LETHARGY (a little lethargic) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (throat had a weird scratchy tickle) and HEART RATE INCREASED (fast heart beating). On 12-Feb-2021, the patient experienced LETHARGY (a little lethargic). The patient was treated with LEVOTHYROXINE SODIUM (SYNTHROID) for Adverse event, at an unspecified dose and frequency. On 11-Feb-2021, OROPHARYNGEAL DISCOMFORT (throat had a weird scratchy tickle) and HEART RATE INCREASED (fast heart beating) had resolved. At the time of the report, LETHARGY (a little lethargic) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.
pt came down with a high fever (102 degrees) during the evening on the day after her vaccination
I got my first shot this week and I felt tired; felt like someone might have grabbed her arm; This is a spontaneous report from a Pfizer-sponsored program, Pfizer RXPathways. A contactable 44-year-old consumer of unspecified gender reported to have received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date in Mar2021, for COVID-19 immunization. Co-suspect drugs also included estrogens conjugated (PREMARIN; vaginal cream) and estrogens conjugated (PREMARIN; tablet), both taken from an unknown date, at unknown dosage, for an unknown indication. Medical history and concomitant medications were not reported. The patient received the first vaccination and felt tired for an hour on an unspecified date in Mar2021. The patient also felt like "someone might have grabbed her arm, kind of arm, not hard but like when you go see a friend you go oh I'm so happy to see you and that was it and it probably lasted for an hour". The patient also stated that never had anything happened to her/him from it and thought the first hour after she/he got it she/he was tired. The action taken in response to the events with estrogens conjugated was unknown. The final events outcome was unknown. Information on the lot/batch number has been requested.
large bruise on arm 7 days later. on 17th got severe itching on stomach, feet, and legs. broke out in hives everywhere, spreading severely to the point where they started touching. progressed through weekend, developed swelling face, lips, and feet.
pt recv vax & devel nausea 2hr p/vax lasting 24hr;no fever or soreness or swelling @ inj site;no vomiting;
Pt reported to pharmacy on 10/16/12 to report possible adverse reaction to flu shot. Pt said about 4 hours after immunization, she experienced restless leg symptoms and pain in her hips that cause difficulty sleeping. These symptoms lasted about 4 days but gradually improved. Pt reported no injection site reaction at all. Pt did not seek medical attention.
Loss of taste; Possibly have covid-19 virus; Loss of smell; Headache; Chills; Soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in arm), AGEUSIA (Loss of taste), SUSPECTED COVID-19 (Possibly have covid-19 virus), ANOSMIA (Loss of smell) and HEADACHE (Headache) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005C21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021 at 8:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-May-2021, the patient experienced PAIN IN EXTREMITY (Soreness in arm) and HEADACHE (Headache). 11-May-2021, the patient experienced CHILLS (Chills). On 12-May-2021, the patient experienced AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell). 12-May-2021, the patient experienced SUSPECTED COVID-19 (Possibly have covid-19 virus). On 13-May-2021, AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell) had resolved. At the time of the report, PAIN IN EXTREMITY (Soreness in arm), SUSPECTED COVID-19 (Possibly have covid-19 virus), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-May-2021, SARS-CoV-2 test: negative (Negative) Negative.         No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events were not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: No specific follow-up information recorded.
doses given after temperature excursion/ Vaccinated after the excursion; Product storage error; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) and PRODUCT STORAGE ERROR (Product storage error) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 28-Nov-2021, the patient experienced PRODUCT STORAGE ERROR (Product storage error). On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion). On 28-Nov-2021, PRODUCT STORAGE ERROR (Product storage error) had resolved. At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The facility had a 20 minute excursion in the freezer that their Moderna vials are stored in.  No concomitant drugs were reported. No treatment drugs were reported.
Patient was given Pfizer COVID-19 vaccine on 12/18/2020.  Given Moderna on 1/19/2021.  No data on interchangeability of the vaccines.
I began having chills which rapidly progressed into severe trembling.  By the time I reached my home, I was barely able to control my body movements. I took 2 Tylenol, crawled under an electric blanket and took my temperature, using an ear thermometer. Temp was 100.7. My normal temp is 97.6. I was trembling so badly that I could not even text my son to come check on me or read the side effects on the Rx sheet. I was finally able to call my son, an EMT, on speed dial. When he got to me about 10 minutes later, he confirmed that I had no breathing problems or rash, only the elevated temperature. My temperature continued to rise during the next 36 hours, eventually reaching 102.6. I was weak, unable to eat, dizzy, and had severe headaches. I treated myself by taking 2 Tylenol every 4-6 hours. I did not seek medical assistance. My temperature did not return to normal until around 04:00 AM on December 6, 2012.
Rash, feet up to her thighs.; She has high blood pressure now.; how bad her kidneys are affected; has a high resting heart rate; diagnosed with HSP; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 12-year-old female patient received BNT162b2 (BNT162B2), on 25Jan2022 as dose 2, single (Lot number: F51614) at the age of 12 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot: number: 330368D, Expiration: Jun2022), administration date: 04Jan2022, when the patient was 12-year-old, for COVID-19 immunization. The following information was reported: HENOCH-SCHONLEIN PURPURA (non-serious) with onset Feb2022, outcome "not recovered", described as "diagnosed with HSP"; RASH (non-serious), outcome "not recovered", described as "Rash, feet up to her thighs."; HYPERTENSION (non-serious), outcome "unknown", described as "She has high blood pressure now."; RENAL DISORDER (non-serious), outcome "unknown", described as "how bad her kidneys are affected"; HEART RATE INCREASED (non-serious), outcome "unknown", described as "has a high resting heart rate". The events "rash, feet up to her thighs." and "how bad her kidneys are affected" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of rash, henoch-schonlein purpura, hypertension.  Additional information: Reporter reported for her daughter. Her and her daughter had adverse effects plus health problems. She wanted to report on her daughter first, since her daughter is worst. Her daughter's kidney specialist said it was from the vaccine. Less than a month after second covid vaccine her daughter got a really bad rash from her feet up to her thighs, and she was taken to the hospital and her doctor sent her to a kidney specialist. She was not admitted to the hospital. Did a lot of blood work and urine. She was diagnosed with HSP in late Feb2022, she does not know what HSP stands for. Treatment: she had to be put on steroids and another medication to get the rash to come down and antibiotics. Rash Outcome: Right now it is at an incline, the rash is not affecting her right now but giving her other problems. She has high blood pressure now and has to be on medication for that. She has a high resting heart rate, sometimes her heart rate goes between 150-160. Stated that the high blood pressure and high heartrate is from the HSP which she states is from the covid vaccine. Doctor did urinalysis and blood work and she is about to do a ultrasound on her kidneys. And will have to do a biopsy of her kidneys where she will have to stay overnight and be put to sleep, and see how bad her kidneys are affected.